THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,191 | -16.6% | 138 | 0.0% | 0.00% | – |
| Q2 2023 | $1,428 | -4.6% | 138 | 0.0% | 0.00% | – |
| Q1 2023 | $1,497 | -25.2% | 138 | 0.0% | 0.00% | – |
| Q4 2022 | $2,000 | +100.0% | 138 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 138 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 138 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -50.0% | 138 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | +100.0% | 138 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 138 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | -33.3% | 138 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | -25.0% | 138 | -36.1% | 0.00% | – |
| Q4 2020 | $4,000 | +33.3% | 216 | 0.0% | 0.00% | – |
| Q3 2020 | $3,000 | -40.0% | 216 | -4.4% | 0.00% | – |
| Q2 2020 | $5,000 | 0.0% | 226 | 0.0% | 0.00% | – |
| Q1 2020 | $5,000 | – | 226 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |